Ticker
EW

Price
76.55
Stock movement down
-1.01 (-1.30%)
Company name
Edwards Lifesciences Corp
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
47.60B
Ent value
49.14B
Price/Sales
8.88
Price/Book
8.14
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
40.88
Forward P/E
26.95
PEG
3.98
EPS growth
5.80%
1 year return
-30.30%
3 year return
-2.08%
5 year return
14.40%
10 year return
18.53%
Last updated: 2022-12-05

DIVIDENDS

EW does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E40.88
Price to OCF27.59
Price to FCF33.32
Price to EBITDA31.47
EV to EBITDA32.50

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales8.88
Price to Book8.14
EV to Sales9.17

FINANCIALS

Per share

Loading...
Per share data
Current share count621.75M
EPS (TTM)1.84
FCF per share (TTM)2.26

Income statement

Loading...
Income statement data
Revenue (TTM)5.36B
Gross profit (TTM)4.10B
Operating income (TTM)1.75B
Net income (TTM)1.16B
EPS (TTM)1.84
EPS (1y forward)2.84

Margins

Loading...
Margins data
Gross margin (TTM)76.58%
Operating margin (TTM)32.58%
Profit margin (TTM)21.73%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.03B
Net receivables686.20M
Total current assets3.24B
Goodwill1.17B
Intangible assets322.00M
Property, plant and equipment0.00
Total assets8.42B
Accounts payable158.80M
Short/Current long term debt688.20M
Total current liabilities949.90M
Total liabilities2.58B
Shareholder's equity5.84B
Net tangible assets4.36B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.72B
Capital expenditures (TTM)296.50M
Free cash flow (TTM)1.43B
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity19.92%
Return on Assets13.83%
Return on Invested Capital18.01%
Cash Return on Invested Capital22.10%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open76.42
Daily high76.98
Daily low75.02
Daily Volume3.16M
All-time high130.68
1y analyst estimate120.05
Beta1.14
EPS (TTM)1.84
Dividend per share-
Ex-div date-
Next earnings date24 Jan 2023

Downside potential

Loading...
Downside potential data
EWS&P500
Current price drop from All-time high-41.42%-14.82%
Highest price drop-50.47%-56.47%
Date of highest drop1 Nov 20009 Mar 2009
Avg drop from high-10.54%-11.46%
Avg time to new high14 days13 days
Max time to new high516 days1805 days
COMPANY DETAILS
EW (Edwards Lifesciences Corp) company logo
Marketcap
47.60B
Marketcap category
Large-cap
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Employees
15700
Investor relations
SEC filings
CEO
Michael Mussallem
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found